Campbell & Co Investment Adviser’s Legend Biotech LEGN Stock Holding History

Campbell & Co Investment Adviser’s Portfolio LEGN Stock Details LEGN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-70,598	Closed	-$1.53M	–	1255
2025 Q4	$1.53M	Buy	+70,598	New	+$2.02M	0.07%	421
2025 Q3	–	Sell	-20,325	Closed	-$721K	–	1254
2025 Q2	$721K	Buy	+20,325	New	+$659K	0.05%	646
2023 Q4	–	Sell	-7,201	Closed	-$484K	–	1225
2023 Q3	$484K	Buy	+7,201	New	+$500K	0.06%	526

Other funds holding LEGN

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return

Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

FBIL

First Beijing Investment Ltd Hong Kong $2.44B AUM 18.47% 1-Year Est. Return

Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Campbell & Co Investment Adviser's LEGN Position: Q1 2026 in Review

Campbell & Co Investment Adviser sold out of Legend Biotech (LEGN) in Q1 2026, closing a stake of 70,598 shares — an estimated $1.53M sold.

Campbell & Co Investment Adviser first reported a position in LEGN in Q3 2023 and held it in 3 quarters. The position peaked at $1.53M in Q4 2025. 191 funds tracked by Wall St. Rank hold LEGN as of Q1 2026.

Campbell & Co Investment Adviser reported no remaining Legend Biotech position as of Q1 2026 after selling out during the quarter.
Campbell & Co Investment Adviser sold 70,598 Legend Biotech shares in Q1 2026, an estimated $1.53M.
Campbell & Co Investment Adviser first reported a position in Legend Biotech in Q3 2023 and held it in 3 quarters.
Campbell & Co Investment Adviser's Legend Biotech position peaked at $1.53M in Q4 2025.
191 funds tracked by Wall St. Rank held Legend Biotech as of Q1 2026.

Based on Campbell & Co Investment Adviser's 13F filing for Q1 2026, filed 15 May 2026.